Tecovirimat in the Treatment of Mpox: Clinical Efficacy and Therapeutic Implications
A comprehensive analysis of tecovirimat's clinical efficacy in mpox treatment demonstrates significant reduction in lesion resolution time and viral shedding duration. The findings establish tecovirimat as a viable therapeutic option for severe mpox infections requiring antiviral intervention.